The results showed that the hepatic portal inflammation, bile duct damage, and fibrosis of the PBC model mice were less severe than those of non-injected model mice, and the levels of TNF-α and TNF-γ in peripheral blood also decreased. Here, TNF is linked to primary biliary cholangitis.